After more than a decade of research, scientists have discovered the natural mechanism behind a novel form of cell death ...

Cancer cells are often described as “glutamine addicted,” relying heavily on this amino acid to fuel growth. But new research reveals how some tumors sidestep this vulnerability.

A newly discovered cancer trick that weakens immunotherapy may be stopped by everyday statins.

A new study by researchers at Wake Forest University School of Medicine has identified a promising strategy to treat brain ...

Scientists at Duke-NUS Medical School have identified a molecular "switch" that determines whether pancreatic cancer cells resist chemotherapy or respond to it—a finding that could help convert some ...

Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more ...

When cancer-driving proteins resist various treatments, Northwestern University scientists have uncovered a new solution. Don't fight them—throw them in the cellular trash. In a new study published in ...

Dr. Anczukow is a leading cancer biologist with expertise in RNA biology, molecular and cell biology, as well as human genetics, cancer biology, and genomics Olga Anczukow, Ph.D. Olga Anczukow, Ph.D.

UConn Center on Aging researchers have published a new editorial in the journal Aging titled "Polyploidy-induced senescence: Linking development, differentiation, repair, and (possibly) cancer?" In ...

Alpha-enolase (ENO1) is a multifunctional enzyme primarily known for its role in glycolysis, where it catalyses the conversion of 2-phosphoglycerate to phosphoenolpyruvate. However, ENO1’s ...

Recognized expert in cancer biology, RNA biology and translational therapeutics with 20 years of experience in preclinical ...